SECONAL SODIUM Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Seconal Sodium, and when can generic versions of Seconal Sodium launch?
Seconal Sodium is a drug marketed by Valeant Pharms North and Lilly and is included in three NDAs.
The generic ingredient in SECONAL SODIUM is secobarbital sodium. There is one drug master file entry for this compound. Additional details are available on the secobarbital sodium profile page.
Summary for SECONAL SODIUM
US Patents: | 0 |
Applicants: | 2 |
NDAs: | 3 |
Raw Ingredient (Bulk) Api Vendors: | 8 |
Patent Applications: | 116 |
Formulation / Manufacturing: | see details |
DailyMed Link: | SECONAL SODIUM at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for SECONAL SODIUM
US Patents and Regulatory Information for SECONAL SODIUM
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Valeant Pharms North | SECONAL SODIUM | secobarbital sodium | CAPSULE;ORAL | 086101-001 | Oct 3, 1983 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Lilly | SECONAL SODIUM | secobarbital sodium | SUPPOSITORY;RECTAL | 086530-004 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Lilly | SECONAL SODIUM | secobarbital sodium | SUPPOSITORY;RECTAL | 086530-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Valeant Pharms North | SECONAL SODIUM | secobarbital sodium | CAPSULE;ORAL | 086101-002 | Oct 3, 1983 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |